Clinical trial
A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
NCT03378635 is registered in ClinicalTrials.gov with Zealand Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomized, Double-blind, Parallel Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus Compared to Placebo and With Reference to GlucaGen
- Lead sponsor
- Zealand Pharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 7, 2017
- Completion date
- May 25, 2018
- Enrollment
- 170 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.